GW Professor William D. Gaillard Named Treasurer of American Epilepsy Society

William D. Gaillard, M.D., professor of neurology and pediatrics at the George Washington University School of Medicine and Health Sciences, was elected treasurer of the American Epilepsy Society (AES) during the society’s 67th annual meeting at the Washington Convention Center.  Gaillard, who is also head of the Division of Neurophysiology, Epilepsy, and Critical Care Neurology at Children’s National Health System, joined the AES board in 2009. AES is the preeminent professional society for physicians and scientists concerned with the prevention, treatment, and research of epilepsy in the United States.

Gaillard is a practicing pediatric neurologist and scientist whose research focuses on the effects of childhood epilepsy on brain structure and function.  He has published more than 180 papers and book chapters with an emphasis on the use of imaging in the investigation of patients with epilepsy.

As an active participant in AES activities, Gaillard has served on the organization’s Council on Education, the Scientific Program, the Annual Meeting Committee, and as chair of the Clinical Investigator Workshop and Pediatric Content Committees.  He also serves as an associate editor for the journals Epilepsia and Epilepsy Research, and as a regular reviewer on AES and Epilepsy Foundation study sections.

Latest News

The ninth annual Art of Science competition highlights the beauty and elegance of ongoing research at GW SMHS.
Julie E. Bauman, MD, led a panel of leading cancer researchers who explored the future of cancer treatment as part of the GW Medicine Bicentennial Lecture Series. The hour-long lecture, titled “Harnessing the Immune System Against Cancer — From Shots to Stem Cells,” delved into innovative therapies…
The George Washington University School of Medicine and Health Sciences Department of Dermatology, in collaboration with the Pennsylvania Avenue Baptist Church and the National Psoriasis Foundation (NPF), announced a renewed funding commitment of $350,000 from Johnson & Johnson in support of…